Novel Specific Metallo-beta-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive Enterobacterales

Zalacain, M; Lozano, C; Llanos, A; Sprynski, N; Valmont, T; De Piano, C; Davies, D; Leiris, S; Sable, C; Ledoux, A; Morrissey, I; Lemonnier, M; Everett, M

Zalacain, M (corresponding author), Antabio SAS, Labege, France.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021; 65 (6):

Abstract

The global dissemination of metallo-beta-lactamase (MBL)-producing carbapenem-resistant Enterobacterales (CRE) is a serious public health concern. Spe......

Full Text Link